Drawing for EC23

USPTO serial 79092293

EC23

Reviewed by CopyMark Law Group

Reg. 4054670Status 404
Filing date
Status date
Registration date
Nov 15, 2011
Examiner
TRUSILO, KELLY JEAN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with EC23?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Miriam D. Trudell

Miriam D. Trudell Sheridan Ross P.C.1560 Broadway, Suite 1200Denver, CO 80202UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Biological preparations for use in the induction of cell differentiation in cell cultures and synthetic small molecules for use in the induction of in-vitro cell differentiation, other than medical; cell growth media for growing cells for use in scientific research; media for cell culture for use, namely, in non-medical research and biotechnological laboratories; chemical preparations for biotechnological purposes, namely, for the induction of cell differentiation, in particular stem cell differentiation; reagents for use in scientific apparatus for chemical or biological analysis; chemical preparations, agents and reagents for use in cellular research; biochemicals, namely, monoclonal antibodies other than for medical or veterinary purposes; biochemicals, namely, antibodies for diagnostic, laboratory, industrial or scientific use other than medical; biochemical products containing antibodies for use in scientific researchSECTION 71 - CANCELLED—
005Pharmaceutical preparations for the treatment of skin and neuro-degenerative diseases; medical biological reagents for use in molecular biology; medical diagnostic reagents; medical diagnostic reagents for in vitro laboratory tests; chemical reagents for medical and veterinary purposes; chemical preparations, agents and reagents for medical and veterinary use, namely, in the differentiation of cell types; biological preparations for the treatment of skin and neuro-degenerative diseases; cell growth media for growing cells for medical or clinical use; diagnostic agents, preparations and substances for medical purposes, namely, for use in binding or detecting antibodies, and in the development of antibodiesSECTION 71 - CANCELLED—
040Batch biological and chemical treatment services of materials; batch biological and chemical material treatment involving cell culture processes and the differentiation of cell typesSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 25, 2021DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Sep 25, 2021DETHDEATH OF INTERNATIONAL REGISTRATION—
May 3, 2019INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Mar 6, 2019INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Mar 6, 2019INPCINVALIDATION PROCESSED—
Feb 22, 2019INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Jun 22, 2018C71TCANCELLED SECTION 71—
Sep 29, 2017NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 15, 2016REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jul 6, 2012FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 20, 2012FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 20, 2012FIMPFINAL DISPOSITION PROCESSED—
Feb 15, 2012FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 15, 2011R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 23, 2011GPNXNOTIFICATION PROCESSED BY IB—
Aug 30, 2011NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 30, 2011PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 10, 2011OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 10, 2011OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 26, 2011PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jul 26, 2011ALIEASSIGNED TO LIE—
Jul 1, 2011CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 27, 2011TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 26, 2011CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 26, 2011TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 26, 2011ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 26, 2011REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 6, 2011RFNTREFUSAL PROCESSED BY IB—
Feb 15, 2011RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Feb 15, 2011RFRRREFUSAL PROCESSED BY MPU—
Feb 15, 2011RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Feb 15, 2011MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 14, 2011CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 11, 2011DOCKASSIGNED TO EXAMINER—
Feb 11, 2011NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 10, 2011REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance